Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

biomarker cerebral amyloid angiopathy cerebrospinal fluid dementia small vessel disease

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2023
Historique:
received: 27 09 2022
revised: 10 03 2023
accepted: 17 05 2023
medline: 30 6 2023
pubmed: 30 6 2023
entrez: 30 6 2023
Statut: epublish

Résumé

Integrating cerebrospinal fluid-biomarkers into diagnostic workup of patients with sporadic cerebral amyloid angiopathy may support early and correct identification. We aimed to identify and validate clinical- and cerebrospinal fluid-biomarkers for

Identifiants

pubmed: 37389304
doi: 10.1093/braincomms/fcad159
pii: fcad159
pmc: PMC10300526
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcad159

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Déclaration de conflit d'intérêts

M.I.S. reports grants from the Interdisciplinary Center for Clinical Research and Marohn Foundation. P.L. received consultation and/or lecture honoraria from IBL International, Fujirebio Europe, AJ Roboscreen, Biogen, and Roche. J.B.K. received speaker honoraria from Sanofi, Biogen, Bayer, Alexion, Boston Scientific, and BI. The other authors report no conflicts of interest related to the contents of the manuscript.

Références

Eur Heart J. 2018 May 14;39(19):1709-1723
pubmed: 29529259
Lancet Neurol. 2021 Aug;20(8):596-597
pubmed: 34237272
Alzheimers Res Ther. 2018 Aug 28;10(1):87
pubmed: 30153863
Cerebrovasc Dis. 2015;39(5-6):278-86
pubmed: 25871492
Neurology. 2001 Feb 27;56(4):537-9
pubmed: 11222803
Neurology. 2018 Feb 27;90(9):e754-e762
pubmed: 29386280
Front Aging Neurosci. 2022 Feb 14;14:783996
pubmed: 35237145
Stroke. 2012 Sep;43(9):2324-30
pubmed: 22798323
J Alzheimers Dis. 2015;48(2):433-41
pubmed: 26402007
J Cereb Blood Flow Metab. 2016 Jan;36(1):40-54
pubmed: 25944592
Stat Med. 2012 Oct 15;31(23):2676-86
pubmed: 22307964
Neurology. 2018 Jan 16;90(3):126-135
pubmed: 29282327
Alzheimers Dement. 2015 Dec;11(12):1480-1488
pubmed: 26079413
Arch Neurol. 1999 Jun;56(6):673-80
pubmed: 10369305
Acta Neuropathol. 2005 Sep;110(3):222-31
pubmed: 16133541
Stroke. 2016 Aug;47(8):2010-6
pubmed: 27338926
N Engl J Med. 2021 Aug 26;385(9):771-774
pubmed: 34320284
Neurology. 2017 Feb 28;88(9):878-884
pubmed: 28130469
J Alzheimers Dis. 2020;74(4):1189-1201
pubmed: 32176643
Stroke. 2018 Feb;49(2):491-497
pubmed: 29335334
Ann Neurol. 2021 Mar;89(3):474-484
pubmed: 33222266
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):124-37
pubmed: 22056963
Front Aging Neurosci. 2018 Apr 16;10:100
pubmed: 29713273
Neurology. 2017 Feb 28;88(9):820-821
pubmed: 28130465
Brain. 2017 Jul 1;140(7):1829-1850
pubmed: 28334869
J Alzheimers Dis. 2022;87(2):791-802
pubmed: 35367960
J Neural Transm (Vienna). 2009 Sep;116(9):1163-7
pubmed: 19653063
Ann Neurol. 2009 Aug;66(2):245-9
pubmed: 19743453
Neurology. 2021 Aug 3;97(5):231-238
pubmed: 34016709
J Cereb Blood Flow Metab. 2015 May;35(5):710-7
pubmed: 25735919
Alzheimers Dement. 2010 May;6(3):257-64
pubmed: 20451874
Neurology. 2010 Apr 27;74(17):1346-50
pubmed: 20421578
J Alzheimers Dis. 2016 Oct 18;54(4):1291-1295
pubmed: 27567848
Stroke. 2011 Feb;42(2):494-7
pubmed: 21164137
Neurology. 2022 May 17;98(20):e1997-e2004
pubmed: 35314501
Stroke. 2009 Jul;40(7):2601-6
pubmed: 19443808
Ann Clin Transl Neurol. 2020 Mar;7(3):363-374
pubmed: 32133793
Stroke. 2022 Jun;53(6):1944-1953
pubmed: 35264008
World J Biol Psychiatry. 2018 Jun;19(4):244-328
pubmed: 29076399
Nat Rev Neurol. 2018 Jul;14(7):387-398
pubmed: 29802354
J Alzheimers Dis. 2016 Nov 19;55(2):813-822
pubmed: 27792012
JAMA. 2015 Feb 24;313(8):824-36
pubmed: 25710659
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Front Hum Neurosci. 2017 Aug 03;11:353
pubmed: 28824393

Auteurs

Jochen A Sembill (JA)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Christoph Lusse (C)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Mathias Linnerbauer (M)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Maximilian I Sprügel (MI)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Anne Mrochen (A)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Michael Knott (M)

Department of Neuroradiology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Tobias Engelhorn (T)

Department of Neuroradiology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Manuel Alexander Schmidt (MA)

Department of Neuroradiology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Arnd Doerfler (A)

Department of Neuroradiology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Timo Jan Oberstein (TJ)

Department of Psychiatry and Psychotherapy, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Juan Manuel Maler (JM)

Department of Psychiatry and Psychotherapy, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Johannes Kornhuber (J)

Department of Psychiatry and Psychotherapy, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

Piotr Lewczuk (P)

Department of Psychiatry and Psychotherapy, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Department of Neurodegeneration Diagnostics, Medical University of Bialystok, and Department of Biochemical Diagnostics, University Hospital of Bialystok, 15-090 Bialystok, Poland.

Veit Rothhammer (V)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Stefan Schwab (S)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Joji B Kuramatsu (JB)

Department of Neurology, University Hospital Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.

Classifications MeSH